A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus

Obesity Reviews

Volumn 17, Issue 8, 2016, Pages 758-769

  Chaudhry, Z W ^a   Doshi, R S ^a   Mehta, A K ^b   Jacobs, D K ^c   Vakil, R M ^d,e   Lee, C J ^a   Bleich, S N ^d   Kalyani, R R ^a   Clark, J M ^a,d,f   Gudzune, K A ^a,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Commercial weight loss; glucose; haemoglobin A1c; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

COCHRANE LIBRARY; DIABETIC PATIENT; GLYCEMIC INDEX; HEALTH CARE MANAGEMENT; HUMAN; INTERMETHOD COMPARISON; LOW CALORY DIET; MEDLINE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE MANAGEMENT; REVIEW; SYSTEMATIC REVIEW; WEIGHT LOSS PROGRAM; WEIGHT REDUCTION;

EID: 84978863295     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12423     Document Type: Review

References (54)

1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: estimates of diabetes and its burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014.
2. Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–79.
3. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009; 28: w822–w831.
4. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 2014; 311: 806–814.
5. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995; 122: 481–486.
6. Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991; 325: 147–152.
7. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
8. Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the look AHEAD trial. Arch Intern Med 2010; 170: 1566–1575.
9. Bloom B, Mehta AK, Clark JM, Gudzune KA. Guideline-concordant weight-loss programs in an urban area are uncommon and difficult to identify through the Internet. Obesity (Silver Spring) 2015(in press).
10. Gudzune KA, Doshi RS, Mehta AK et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med 2015; 162: 501–512.
11. Gannon MC, Nuttall FQ. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes 2004; 53: 2375–2382.
12. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 2005; 142: 56–66.
13. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 2006; 113: 2943–2946.
14. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration; 2011. Accessed at http://www.cochrane-handbook.org on 1 October 2013.
15. Rock CL, Flatt SW, Pakiz B et al. Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. Diabetes Care 2014; 37: 1573–1580.
16. Foster GD, Borradaile KE, Vander Veur SS et al. The effects of a commercially available weight loss program among obese patients with type 2 diabetes: a randomized study. Postgrad Med 2009; 121: 113–118.
17. Foster GD, Wadden TA, Lagrotte CA et al. A randomized comparison of a commercially available portion-controlled weight-loss intervention with a diabetes self-management education program. Nutr Diabetes 2013; 3: e63.
18. Wing RR, Blair E, Marcus M, Epstein LH, Harvey J. Year-long weight loss treatment for obese patients with type II diabetes: does including an intermittent very-low-calorie diet improve outcome? Am J Med 1994; 97: 354–362.
19. Li Z, Go VL, DeShields S et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005; 59: 411–418.
20. Yip I, Go VL, DeShields S et al. Liquid meal replacements and glycemic control in obese type 2 diabetes patients. Obes Res 2001; 9(Suppl4): S341–S347.
21. Davis NJ, Tomuta N, Schechter C et al. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care 2009; 32: 1147–1152.
22. Shai I, Schwarzfuchs D, Henkin Y et al. Dietary intervention randomized controlled trial (DIRECT) group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359: 229–241.
23. Greenberg I, Stampfer MJ, Schwarzfuchs D, Shai I, DIRECT Group. Adherence and success in long-term weight loss diets: the Dietary Intervention Randomized Controlled Trial (DIRECT). J Am Coll Nutr 2009; 28: 159–168.
24. Tirosh A, Golan R, Harman-Boehm I et al. Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial. Diabetes Care 2013; 36: 2225–2232.
25. Heshka S, Greenway F, Anderson JW et al. Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study. Am J Med 2000; 109: 282–287.
26. Heshka S, Anderson JW, Atkinson RL et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003; 289: 1792–1798.
27. Jebb SA, Ahern AL, Olson AD et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011; 378: 1485–1492.
28. Walker CG, Holzapfel C, Loos RJ et al. Genetic predisposition to an adverse lipid profile limits the improvement in total cholesterol in response to weight loss. Obesity (Silver Spring) 2013; 21: 2589–2595.
29. Truby H, Baic S, deLooy A et al. Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC “Diet Trials”. BMJ 2006; 332: 1309–1314.
30. Morgan LM, Griffin BA, Millward DJ et al. Comparison of the effects of four commercially available weight-loss programmes on lipid-based cardiovascular risk factors. Public Health Nutr 2009; 12: 799–807.
31. Anderson JW, Reynolds R, Bush HM, Rinsky JL, Washnock C. Effect of a behavioral/nutritional intervention program on weight loss in obese adults: a randomized controlled trial. Postgrad Med 2011; 123: 205–213.
32. Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr 1999; 69: 198–204.
33. Flechtner-Mors M, Ditschuneit HH, Johnson TD, Suchard MA, Adler G. Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res 2000; 8: 399–402.
34. Ditschuneit HH, Flechtner-Mors M. Value of structured meals for weight management: risk factors and long-term weight maintenance. Obes Res 2001; 9(Suppl4): S284–S289.
35. Ditschuneit HH, Frier HI, Flechtner-Mors M. Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects. Eur J Clin Nutr 2002; 56: 264–270.
36. Noakes M, Foster PR, Keogh JB, Clifton PM. Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome. J Nutr 2004; 134: 1894–1899.
37. Clifton PM, Keogh JB, Foster PR, Noakes M. Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int J Obes (Lond) 2005; 29: 1445–1451.
38. Gardner CD, Kiazand A, Alhassan S et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight pre- menopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA 2007; 297: 969–977.
39. Moore SD, King AC, Kiernan M, Gardner CD. Outcome expectations and realizations as predictors of weight regain among dieters. Eat Behav 2011; 12: 60–63.
40. McAuley KA, Hopkins CM, Smith KJ et al. Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia 2005; 48: 8–16.
41. Collins CE, Morgan PJ, Jones P et al. Evaluation of a commercial web-based weight loss and weight loss maintenance program in overweight and obese adults: a randomized controlled trial. BMC Public Health 2010; 10: 669.
42. Collins CE, Morgan PJ, Jones P et al. A 12-week commercial web-based weight-loss program for overweight and obese adults: randomized controlled trial comparing basic versus enhanced features. J Med Internet Res 2012; 14: e57.
43. Hutchesson MJ, Collins CE, Morgan PJ, Watson JF, Guest M, Callister R. Changes to dietary intake during a 12-week commercial web-based weight loss program: a randomized controlled trial. Eur J Clin Nutr 2014; 68: 64–70.
44. Levers K, Baetge C, Lockard B et al. Effects of exercise and diet-induced weight loss on markers of inflammation: impact on body composition and markers of health and fitness. Accessed at http://exerciseandsportnutritionlab.com/Portals/70/2031%20ISSN%20Posters.pdf on 10 November 2014.
45. Jung YP, Lockard B, Baetge C et al. Adherence to a high protein and low fat energy-restricted diet while participating in a circuit resistance-exercise program promotes fat loss with no loss in fat free mass in post-menopausal women. Accessed at http://exerciseandsportnutritionlab.com/Portals/70/2013%20FASEB%20Posters.pdf on 10 November 2014.
46. Jagim A, Byrd M, Lockard B et al. Adherence to a high protein and low fat energy-restricted diet while participating in a circuit resistance-exercise program promotes positive changes in blood glucose and lipids in post-menopausal women. Accessed at http://exerciseandsportnutritionlab.com/Portals/70/2013%20FASEB%20Posters.pdf on 10 November 2014.
47. American Diabetes Association. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2016; 39(Suppl1): S47–S51.
48. Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 2007; 30: 1374–1383.
49. Pronk NP, Remington PL. Combined diet and physical activity promotion programs for prevention of diabetes: community preventive services task force recommendation statement. Ann Intern Med 2015; 163: 465–468.
50. IBISWorld. Weight loss services in the U.S. industry market re- search report; June 2014. Los Angeles: IBISWorld; 2014. Accessed at http://clients1.ibisworld.com/reports/us/industry/default.aspx?entid=1719 on 25 August 2014.
51. Esposito K, Maiorino MI, Ciotola M et al. Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial. Ann Intern Med 2009; 151: 306–314.
52. Turner-McGrievy GM, Barnard ND, Cohen J, Jenkins DJA, Gloede L, Green AA. Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. J Am Diet Assoc 2008; 108: 1636–1645.
53. Marrero DG, Palmer KN, Phillips EO, Miller-Kovach K, Foster GD, Saha CK. Comparison of commercial and self-initiated weight loss programs in people with prediabetes: a randomized control trial. Am J Public Health 2016: e1–e8.
54. National Diabetes Prevention Program. Accessed at http://www.cdc.gov/diabetes/prevention/recognition/index.htm on 21 July 2015.